Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-07

Clinical Trial Update: The Optimization of Bioavailability From Iron Supplements: Study 1 [NA]

View source ↗

Summary

A completed trial update on optimizing the bioavailability of iron supplements (Study 1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron supplement (unspecified) (Iron supplement)

Snippet

Sponsor: Swiss Federal Institute of Technology | Conditions: Iron Deficiency, Anemia | NA | Status: COMPLETED